Polyrizon (PLRZ) Competitors $1.02 -0.05 (-4.67%) As of 09/5/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PLRZ vs. FBLG, ENLV, RLYB, AKTX, THAR, ALVR, NAII, PASG, PMN, and NNVCShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include FibroBiologics (FBLG), Enlivex Therapeutics (ENLV), Rallybio (RLYB), Akari Therapeutics (AKTX), Tharimmune (THAR), AlloVir (ALVR), Natural Alternatives International (NAII), Passage Bio (PASG), Promis Neurosciences (PMN), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Its Competitors FibroBiologics Enlivex Therapeutics Rallybio Akari Therapeutics Tharimmune AlloVir Natural Alternatives International Passage Bio Promis Neurosciences NanoViricides Polyrizon (NASDAQ:PLRZ) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations. Is PLRZ or FBLG more profitable? Polyrizon's return on equity of 0.00% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets PolyrizonN/A N/A N/A FibroBiologics N/A -710.25%-118.02% Do analysts recommend PLRZ or FBLG? FibroBiologics has a consensus target price of $13.00, suggesting a potential upside of 2,163.63%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts clearly believe FibroBiologics is more favorable than Polyrizon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to PLRZ or FBLG? In the previous week, Polyrizon and Polyrizon both had 1 articles in the media. Polyrizon's average media sentiment score of 0.00 equaled FibroBiologics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polyrizon 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral FibroBiologics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, PLRZ or FBLG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyrizonN/AN/A-$1.54MN/AN/AFibroBiologicsN/AN/A-$11.16M-$0.36-1.60 SummaryPolyrizon and FibroBiologics tied by winning 3 of the 6 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.11M$3.18B$5.83B$9.93BDividend YieldN/A2.27%6.70%4.52%P/E RatioN/A21.1076.1526.11Price / SalesN/A466.44562.61123.62Price / CashN/A45.7236.9959.28Price / Book0.009.8711.486.09Net Income-$1.54M-$53.42M$3.29B$266.51M7 Day Performance-6.42%2.93%1.27%0.46%1 Month Performance-11.30%9.85%7.94%4.59%1 Year PerformanceN/A15.74%62.94%26.04% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$1.02-4.7%N/AN/A$6.11MN/A0.00N/ANews CoverageGap DownFBLGFibroBiologics2.262 of 5 stars$0.60-0.3%$13.00+2,063.1%-69.1%$25.18MN/A-1.6710Gap UpENLVEnlivex Therapeutics3.5125 of 5 stars$1.04-1.9%$10.00+861.5%-13.8%$24.60MN/A-1.5870News CoverageAnalyst ForecastShort Interest ↓Analyst RevisionRLYBRallybio2.9842 of 5 stars$0.59+1.6%$5.00+751.8%-45.2%$24.53M$640K-0.6240Short Interest ↓Gap UpAKTXAkari Therapeutics3.0808 of 5 stars$0.74+13.0%$5.00+575.7%-76.5%$23.81MN/A0.009News CoverageShort Interest ↑Gap UpTHARTharimmune2.7956 of 5 stars$4.05-15.1%$17.00+319.8%+26.9%$23.18MN/A-0.672News CoverageShort Interest ↑Gap UpALVRAlloVirN/A$4.57+14.3%N/A-73.4%$23.05MN/A-0.23110Gap DownHigh Trading VolumeNAIINatural Alternatives InternationalN/A$3.73+2.7%N/A-47.4%$23.05M$113.80M-2.68290Positive NewsPASGPassage Bio3.4777 of 5 stars$7.130.0%$75.67+961.7%-44.4%$22.40MN/A-0.39130Positive NewsAnalyst UpgradePMNPromis Neurosciences2.8402 of 5 stars$0.43-5.8%$4.33+905.4%-68.6%$22.33MN/A-2.055Gap DownNNVCNanoViricides0.7338 of 5 stars$1.39-3.1%N/A-16.3%$22.26MN/A-1.9220Positive NewsShort Interest ↓ Related Companies and Tools Related Companies FibroBiologics Alternatives Enlivex Therapeutics Alternatives Rallybio Alternatives Akari Therapeutics Alternatives Tharimmune Alternatives AlloVir Alternatives Natural Alternatives International Alternatives Passage Bio Alternatives Promis Neurosciences Alternatives NanoViricides Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredHamilton’s 100-to-1 tradePorter Stansberry has made a career out of bold calls that go against the mainstream narrative — from the 1998...Porter & Company | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.